Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2401–2406. doi: 10.1158/1055-9965.EPI-10-0503

Table 1.

Cutaneous malignant melanoma from SEER 9 Registries Database, 1975-2006

All cases Females Males
Total n 105,829 48,183 57,646
% of total cases 100% 45.5% 54.5%
Rate 17.7 15.2 21.4
Mean age 55.7 53.0 57.9

All cases Females Males IRRFemale:Male (95% CI)
Variable N Rate N Rate N Rate

Age at Diagnosis
 <20 years 1,036 0.6 628 0.7 408 0.5 1.6 (1.4, 1.8)
 20-29 years 6,598 6.8 4,212 8.9 2,386 4.8 1.8 (1.7, 1.9)
 30-39 years 13,987 14.6 8,069 17.0 5,918 12.3 1.3 (1.3, 1.4)
 40-49 years 18,635 22.5 9,225 22.3 9,410 22.8 1.0 (0.9, 1.0)
 50-59 years 19,941 30.4 8,395 25.3 11,546 35.8 0.7 (0.6, 0.7)
 60-69 years 19,040 39.5 7,016 27.4 12,024 53.2 0.5 (0.5, 0.6)
 70-79 years 16,614 49.6 6,177 31.7 10,437 74.7 0.4 (0.4, 0.5)
 80+ years 9,978 53.3 4,461 35.4 5,517 90.1 0.3 (0.3, 0.4)

Anatomic site
 Face/head/neck 20,643 3.5 6,701 2.0 13,942 5.5 0.3 (0.3, 0.4)
 Trunk 35,155 5.9 12,003 3.9 23,152 8.3 0.4 (0.4, 0.5)
 Upper Extremity 24,584 4.1 12,328 3.9 12,256 4.5 0.9 (0.8, 0.9)
 Lower Extremity 20,589 3.4 15,391 4.9 5,198 1.9 2.6 (2.6, 2.7)
 Othera 4,858 0.8 1,760 0.6 3,098 1.2 0.5 (0.4, 0.5)

Legend: Rates are per 100,000 and age-adjusted to the 2000 US Standard Population (Census P25-1130) Incidence rates and confidence intervals were derived from SEER*Stat software program 6.52. Relative risks were expressed as incidence rate ratios (IRRs), where a given characteristic was compared to a referent characteristic with an assigned IRR of 1.0.

Confidence intervals (δ method) are 95% for IRR (incidence rate ratios).

a

“Other” includes tumors coded as skin, not otherwise specified in SEER